Persistent URL of this record https://hdl.handle.net/1887/101646
In Collections
This item can be found in the following collections:
![MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial
- All authors
- Behrens, F.; Tak, P.P.; Ostergaard, M.; Stoilov, R.; Wiland, P.; Huizinga, T.W.; Berenfus, V.Y.; Vladeva, S.; Rech, J.; Rubbert-Roth, A.; Korkosz, M.; Rekalov, D.; Zupanets, I.A.; Ejbjerg, B.J.; Geiseler, J.; Fresenius, J.; Korolkiewicz, R.P.; Schottelius, A.J.; Burkhardt, H.
- Date
- 2015-06-30
- Journal
- Annals of the Rheumatic Diseases
- Volume
- 74
- Issue
- 6
- Pages
- 1058 - 1064